tradingkey.logo

Senestech Inc

SNES
1.870USD
+0.090+5.06%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
9.77MMarktkapitalisierung
VerlustKGV TTM

Senestech Inc

1.870
+0.090+5.06%

mehr Informationen über Senestech Inc Unternehmen

SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.

Senestech Inc Informationen

BörsenkürzelSNES
Name des UnternehmensSenestech Inc
IPO-datumDec 08, 2016
CEOFruendt (Joel L)
Anzahl der mitarbeiter23
WertpapierartOrdinary Share
GeschäftsjahresendeDec 08
Addresse777 W. Pinnacle Peak Road
StadtPHOENIX
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl85027
Telefon19287794143
Websitehttps://senestech.com/
BörsenkürzelSNES
IPO-datumDec 08, 2016
CEOFruendt (Joel L)

Führungskräfte von Senestech Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Matthew K. (Matt) Szot, CPA
Mr. Matthew K. (Matt) Szot, CPA
Independent Director
Independent Director
1.00
-1.00%
Mr. Thomas C. (Tom) Chesterman
Mr. Thomas C. (Tom) Chesterman
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
--
--
Dr. Jamie Bechtel, J.D., Ph.D.
Dr. Jamie Bechtel, J.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Phil N. Grandinetti, III
Mr. Phil N. Grandinetti, III
Independent Director
Independent Director
--
--
Mr. Jake S. Leach
Mr. Jake S. Leach
Independent Director
Independent Director
--
--
Mr. Joel L. Fruendt
Mr. Joel L. Fruendt
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Joshua M. Moss
Mr. Joshua M. Moss
Independent Director
Independent Director
--
--
Ms. Lynn Y. Graham
Ms. Lynn Y. Graham
Independent Director
Independent Director
--
--
Mr. Michael Edell
Mr. Michael Edell
Chief Operating Officer
Chief Operating Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Matthew K. (Matt) Szot, CPA
Mr. Matthew K. (Matt) Szot, CPA
Independent Director
Independent Director
1.00
-1.00%
Mr. Thomas C. (Tom) Chesterman
Mr. Thomas C. (Tom) Chesterman
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
--
--
Dr. Jamie Bechtel, J.D., Ph.D.
Dr. Jamie Bechtel, J.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Phil N. Grandinetti, III
Mr. Phil N. Grandinetti, III
Independent Director
Independent Director
--
--
Mr. Jake S. Leach
Mr. Jake S. Leach
Independent Director
Independent Director
--
--
Mr. Joel L. Fruendt
Mr. Joel L. Fruendt
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Wed, Mar 5
Währung: USDAktualisiert: Wed, Mar 5
FY2024Q2
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
459.00K
0.00%
International
0.00
0.00%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sun, Feb 1
Aktualisiert: Sun, Feb 1
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Glenbrook Capital Management
11.37%
PFS Cap MGT Co
4.21%
Renaissance Technologies LLC
2.02%
Sabby Management, LLC
1.36%
The Vanguard Group, Inc.
1.31%
Andere
79.72%
Aktionäre
Aktionäre
Anteil
Glenbrook Capital Management
11.37%
PFS Cap MGT Co
4.21%
Renaissance Technologies LLC
2.02%
Sabby Management, LLC
1.36%
The Vanguard Group, Inc.
1.31%
Andere
79.72%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
15.03%
Corporation
4.21%
Investment Advisor/Hedge Fund
2.87%
Investment Advisor
2.63%
Research Firm
0.20%
Andere
75.06%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
34
578.80K
11.18%
+387.29K
2025Q3
27
159.90K
3.23%
+38.59K
2025Q2
29
110.88K
6.13%
-56.71K
2025Q1
31
108.03K
6.02%
-48.91K
2024Q4
32
178.31K
17.25%
+80.51K
2024Q3
38
76.44K
15.87%
+51.77K
2024Q2
37
16.40K
4.22%
-8.22K
2024Q1
40
19.23K
5.47%
+9.13K
2023Q4
37
6.33K
7.03%
+618.00
2023Q3
35
1.33K
4.01%
+245.00
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Glenbrook Capital Management
90.00K
1.72%
+90.00K
--
Sep 30, 2025
PFS Cap MGT Co
220.00K
4.21%
+129.49K
+143.08%
Jun 30, 2025
Renaissance Technologies LLC
105.64K
2.02%
+105.64K
--
Sep 30, 2025
Sabby Management, LLC
71.28K
1.36%
+71.28K
--
Sep 30, 2025
The Vanguard Group, Inc.
61.36K
1.17%
+47.86K
+354.63%
Sep 30, 2025
Corsair Capital Management, L.P.
55.15K
1.06%
+5.10K
+10.19%
Sep 30, 2025
Geode Capital Management, L.L.C.
35.80K
0.69%
+24.15K
+207.36%
Sep 30, 2025
DRW Securities, LLC
30.29K
0.58%
+30.29K
--
Sep 30, 2025
Millennium Management LLC
28.71K
0.55%
+28.71K
--
Sep 30, 2025
Essex Investment Management Company, LLC
26.18K
0.5%
+26.18K
--
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Jul 23, 2024
Merger
10→1
Jul 23, 2024
Merger
10→1
Jul 23, 2024
Merger
10→1
Jul 23, 2024
Merger
10→1
Nov 15, 2023
Merger
12→1
Nov 15, 2023
Merger
12→1
Datum
Ex-Dividendentag
Art
Verhältnis
Jul 23, 2024
Merger
10→1
Jul 23, 2024
Merger
10→1
Jul 23, 2024
Merger
10→1
Jul 23, 2024
Merger
10→1
Nov 15, 2023
Merger
12→1
Nov 15, 2023
Merger
12→1
Nov 15, 2023
Merger
12→1
Nov 15, 2023
Merger
12→1
Nov 15, 2022
Merger
20→1
Nov 15, 2022
Merger
20→1
Mehr Anzeigen
KeyAI